We have located links that may give you full text access.
English Abstract
Journal Article
Research Support, Non-U.S. Gov't
[Analysis of the candidate antigen for Harada's disease].
Nippon Ganka Gakkai Zasshi 1994 June
The candidate antigen for Vogt-Koyanagi-Harada's (VKH) disease was isolated from cultured human melanoma cells (G-361). First, the soluble protein from the melanoma cells was separated into several fractions according to the molecular weight by gel filtration. In each fraction, the antigenicity was analysed by lymphocyte proliferation assay using peripheral blood lymphocytes (PBLs) from VKH disease patients. Then the positive fractions were further separated by liquid isoelectrofocusing followed by SDS polyacrylamide gel electrophoresis. In the liquid isoelectrofocusing fractions, the fraction at about pH 6.0 contained the antigenic protein. The protein from the 75 kDa band on the SDS-PAGE of this fraction was able to cause proliferation of the PBLs from the VKH disease patients. Thus, it appears that the 75 kDa protein of pH 6.0 isoelectrofocusing point was the specific autoimmune antigen for VKH disease.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app